Clinical and genetic profile of patients enrolled in the Transthyretin Amyloidosis Outcomes Survey (THAOS): 14-year update
2022 · Orphanet Journal of Rare Diseases · 82 citations
https://doi.org/10.1186/s13023-022-02359-w
L
Leslie Amass
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
95
Papers
4.2K
Citations
36
h-index
64
i10-index
Leslie Amass is an academic researcher from Pfizer (United States). The author has contributed to research in topics: Amyloidosis: Diagnosis, Treatment, Outcomes & Opioid Use Disorder Treatment & Parathyroid Disorders and Treatments. The author has an h-index of 36, co-authored 81 publications.
Papers by this author
worksSex-Related Risk of Cardiac Involvement in Hereditary Transthyretin Amyloidosis
2021 · JACC Heart Failure · 67 citations
https://doi.org/10.1016/j.jchf.2021.05.005
Epidemiological and clinical characteristics of symptomatic hereditary transthyretin amyloid polyneuropathy: a global case series
2019 · Orphanet Journal of Rare Diseases · 66 citations
https://doi.org/10.1186/s13023-019-1000-1
A Descriptive Analysis of ATTR Amyloidosis in Spain from the Transthyretin Amyloidosis Outcomes Survey
2021 · Neurology and Therapy · 22 citations
https://doi.org/10.1007/s40120-021-00267-y
Clinical and Genotype Characteristics and Symptom Migration in Patients With Mixed Phenotype Transthyretin Amyloidosis from the Transthyretin Amyloidosis Outcomes Survey
2023 · Cardiology and Therapy · 20 citations
https://doi.org/10.1007/s40119-023-00344-3
Phenotypic Differences of Glu89Gln Genotype in ATTR Amyloidosis From Endemic Loci: Update From THAOS
2021 · Cardiology and Therapy · 15 citations
https://doi.org/10.1007/s40119-021-00226-6
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat